Implementation of a proton pump inhibitor stewardship program
- PMID: 28596229
- DOI: 10.2146/ajhp160670
Implementation of a proton pump inhibitor stewardship program
Abstract
Purpose: The development and implementation of a proton pump inhibitor (PPI) stewardship program at a single institution are described.
Summary: Due to the overuse of PPIs and the increasing awareness of the adverse drug events associated with long-term PPI therapy, the pharmacy and internal medicine services of a medical center implemented a PPI stewardship program. All patients admitted to the internal medicine service were evaluated by the PPI stewardship team to determine if they had an appropriate indication for PPI continuation in the hospital as well as after discharge. If patients did not meet specified criteria for continuation of PPI use during hospitalization, PPI therapy was suspended and replaced by as-needed acid suppressive therapy, and the patients received discharge counseling regarding the implemented medication regimen changes. Challenges encountered during program development included establishing appropriate criteria for PPI continuation and determining the best method for discontinuing PPIs in order to reduce the risk of rebound hyperacidity.
Conclusion: In an effort to reduce unnecessary PPI use, a PPI stewardship program was developed and implemented to ensure appropriate continuation of PPIs for patients admitted and discharged from an internal medicine service.
Keywords: antacids; anti-ulcer agents; gastric acid; gastroesophageal reflux; gastrointestinal tract; proton pump inhibitor.
Copyright © 2017 by the American Society of Health-System Pharmacists, Inc. All rights reserved.
Similar articles
-
Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.Hosp Pharm. 2018 Feb;53(1):59-67. doi: 10.1177/0018578717747192. Epub 2017 Dec 13. Hosp Pharm. 2018. PMID: 29434389 Free PMC article.
-
Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.J Manag Care Pharm. 2009 May;15(4):344-50. doi: 10.18553/jmcp.2009.15.4.344. J Manag Care Pharm. 2009. PMID: 19422274 Free PMC article.
-
Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting.Consult Pharm. 2013 Dec;28(12):786-92. doi: 10.4140/TCP.n.2013.786. Consult Pharm. 2013. PMID: 24322962
-
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.Indian J Gastroenterol. 2023 Oct;42(5):601-628. doi: 10.1007/s12664-023-01428-7. Epub 2023 Sep 12. Indian J Gastroenterol. 2023. PMID: 37698821 Review.
-
Is there a dark side to long-term proton pump inhibitor therapy?Am J Ther. 2008 Nov-Dec;15(6):536-42. doi: 10.1097/MJT.0b013e31817149bf. Am J Ther. 2008. PMID: 19127138 Review.
Cited by
-
Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia.Int J Gen Med. 2021 Aug 30;14:5079-5089. doi: 10.2147/IJGM.S328914. eCollection 2021. Int J Gen Med. 2021. PMID: 34511990 Free PMC article.
-
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people.Eur J Clin Pharmacol. 2020 Mar;76(3):459-465. doi: 10.1007/s00228-019-02815-w. Epub 2019 Dec 18. Eur J Clin Pharmacol. 2020. PMID: 31853593
-
Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.Hosp Pharm. 2018 Feb;53(1):59-67. doi: 10.1177/0018578717747192. Epub 2017 Dec 13. Hosp Pharm. 2018. PMID: 29434389 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources